Children ’s Mercy patients benefit from first FDA-approved cancer gene therapy
Children's Mercy patients participated in a clinical trial of Novartis' new cancer treatment.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Elise Reuter Source Type: news
More News: Cancer | Cancer & Oncology | Children | Clinical Trials | Gene Therapy | Genetics | Health Management | Pharmaceuticals